JP2007507270A5 - - Google Patents

Download PDF

Info

Publication number
JP2007507270A5
JP2007507270A5 JP2006530586A JP2006530586A JP2007507270A5 JP 2007507270 A5 JP2007507270 A5 JP 2007507270A5 JP 2006530586 A JP2006530586 A JP 2006530586A JP 2006530586 A JP2006530586 A JP 2006530586A JP 2007507270 A5 JP2007507270 A5 JP 2007507270A5
Authority
JP
Japan
Prior art keywords
hydroxy
formoterol fumarate
fumarate dihydrate
drug
oxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006530586A
Other languages
English (en)
Japanese (ja)
Other versions
JP4589928B2 (ja
JP2007507270A (ja
Filing date
Publication date
Priority claimed from SE0302665A external-priority patent/SE0302665D0/xx
Application filed filed Critical
Publication of JP2007507270A publication Critical patent/JP2007507270A/ja
Publication of JP2007507270A5 publication Critical patent/JP2007507270A5/ja
Application granted granted Critical
Publication of JP4589928B2 publication Critical patent/JP4589928B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006530586A 2003-10-07 2004-10-04 乾燥粉末吸入器 Expired - Fee Related JP4589928B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0302665A SE0302665D0 (sv) 2003-10-07 2003-10-07 Novel Process
PCT/GB2004/004202 WO2005035036A1 (en) 2003-10-07 2004-10-04 Dry powder inhaler

Publications (3)

Publication Number Publication Date
JP2007507270A JP2007507270A (ja) 2007-03-29
JP2007507270A5 true JP2007507270A5 (enExample) 2007-07-26
JP4589928B2 JP4589928B2 (ja) 2010-12-01

Family

ID=29398687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006530586A Expired - Fee Related JP4589928B2 (ja) 2003-10-07 2004-10-04 乾燥粉末吸入器

Country Status (15)

Country Link
US (2) US7896005B2 (enExample)
EP (1) EP1680163A1 (enExample)
JP (1) JP4589928B2 (enExample)
KR (1) KR101110444B1 (enExample)
CN (2) CN1889991B (enExample)
AU (1) AU2004280109B2 (enExample)
BR (1) BRPI0415189A (enExample)
CA (1) CA2541374C (enExample)
IL (1) IL174735A (enExample)
MX (1) MXPA06003872A (enExample)
NO (1) NO336190B1 (enExample)
NZ (1) NZ546405A (enExample)
SE (1) SE0302665D0 (enExample)
WO (1) WO2005035036A1 (enExample)
ZA (1) ZA200602831B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1015883A3 (fr) * 2004-06-08 2005-10-04 Occhio Procede et dispositif de dispersion de poudres seches.
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CN102325532B (zh) 2008-10-07 2015-06-17 Mpex医药有限公司 用于减轻肺部炎症的左氧氟沙星吸入剂
AU2009302478B2 (en) 2008-10-07 2015-09-03 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
GB0912373D0 (en) 2009-07-16 2009-08-26 Innovata Biomed Ltd Improvements in or relating to dry powder inhalers
LT2473170T (lt) 2009-09-04 2019-10-10 Horizon Orphan Llc Aerozolizuoto levofloksacino panaudojimas cistinės fibrozės gydymui
GB201118188D0 (en) * 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
US11052202B2 (en) * 2012-11-07 2021-07-06 Chiesi Farmaceutici S.P.A. Drug delivery device for the treatment of patients with respiratory diseases
WO2015133909A1 (en) * 2014-03-03 2015-09-11 Nexus6 Limited A compliance monitor for a dry powder medicament delivery device
NO2709641T3 (enExample) 2014-03-10 2018-05-12
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
MX2018016046A (es) 2016-06-27 2019-05-02 Achillion Pharmaceuticals Inc Quinazolina y compuestos indol para tratar trastornos medicos.
CA3053818A1 (en) 2017-03-01 2018-09-07 Achillion Pharmaceuticals, Inc. Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
CN108771761B (zh) * 2018-08-16 2021-12-14 上海方予健康医药科技有限公司 一种糖皮质激素与β2受体激动剂的复方干粉吸入剂的制备工艺
EP3841086B1 (en) 2018-08-20 2025-04-23 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
CN113365617B (zh) 2018-10-16 2025-12-23 乔治亚州立大学研究基金会股份有限公司 用于医学疾病治疗的一氧化碳前药
MX2021011507A (es) 2019-03-22 2021-12-15 Achillion Pharmaceuticals Inc Compuestos farmaceuticos para el tratamiento de trastornos mediados por complemento.
CN114845708A (zh) 2019-12-19 2022-08-02 乔治亚州大学研究基金会 用于治疗细菌感染和增强抗生素的化合物
JP2023515073A (ja) 2020-02-20 2023-04-12 アキリオン ファーマシューティカルズ, インコーポレーテッド 補体因子d媒介障害の処置用のヘテロアリール化合物
USD949321S1 (en) * 2020-05-29 2022-04-19 NuvoAir AB Housing for an add-on sensor for an inhaler
CA3193488A1 (en) 2020-09-23 2022-03-31 Jason Allan Wiles Pharmaceutical compounds for the treatment of complement mediated disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069715B1 (en) * 1981-07-08 1986-11-05 Aktiebolaget Draco Powder inhalator
SE9400257D0 (sv) * 1994-01-27 1994-01-27 Astra Ab Spacer
SE9400570D0 (sv) 1994-02-21 1994-02-21 Astra Ab Inhalation device, inhaler and processing unit
US6119853A (en) * 1998-12-18 2000-09-19 Glaxo Wellcome Inc. Method and package for storing a pressurized container containing a drug
US6390291B1 (en) * 1998-12-18 2002-05-21 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6315112B1 (en) * 1998-12-18 2001-11-13 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
GB2353222B (en) * 1999-06-23 2001-09-19 Cambridge Consultants Inhalers
GB0107106D0 (en) 2001-03-21 2001-05-09 Boehringer Ingelheim Pharma Powder inhaler formulations
WO2003035028A1 (en) 2001-10-19 2003-05-01 Nektar Therapeutics Modulating charge density to produce improvements in the characteristics of spray-dried proteins
GB0130857D0 (en) * 2001-12-22 2002-02-06 Glaxo Group Ltd Medicament dispenser

Similar Documents

Publication Publication Date Title
US8205611B2 (en) Dry powder inhaler
JP5207976B2 (ja) 吸入用粉体組成物
Islam et al. Dry powder inhalers (DPIs)—a review of device reliability and innovation
Hou et al. Practical, regulatory and clinical considerations for development of inhalation drug products
US20090250058A1 (en) Inhalation System and Delivery Device for the Administration of a Drug in the Form of Dry Powder
JP2006511257A (ja) 医薬送達用システムに使用するための管状ノズル
JP6943526B2 (ja) 乾燥粉末吸入装置
JP2007509941A5 (enExample)
KR20150010757A (ko) 신규한 투약량 및 제형
AU2015288166B2 (en) Inhalation device
KR101992171B1 (ko) 건조분말 흡입기
JP2006511297A5 (enExample)
JP2006511297A (ja) ベント型マウスピースを有する投薬システム
JP2004529108A (ja) R−サルメテロールおよびプロピオン酸フルチカゾンを含んでなる医薬製剤
RU2020112519A (ru) Ингалятор и сетка для ингалятора
EP1691839A1 (en) Combined doses
JP2004523536A (ja) 薬剤
US20150202392A1 (en) Metering element for an inhalation device and inhalation device comprising a metering element
WO2023128916A1 (en) An apparatus with a grid (10) for the preparation of dry powder compositions for inhalation
WO2004101043A1 (en) Novel treatment